Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00106496 · ClinicalTrials.gov registry record · Phase 4
A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis
A Phase 4 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 4
- Development phase
- 410
- Enrollment target
NCT00106496: Completed Phase 4 study, sponsored by Astellas Pharma.
NCT00106496 is a Phase 4 study that has completed, run by Astellas Pharma. The registered enrollment target is 410 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (21% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00106496, a Phase 4 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 410 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the impact of topical corticosteroids on the safety and effectiveness of Protopic Ointment in the short-term treatment of moderate to severe Atopic Dermatitis and to compare the safety and effectiveness of Protopic Ointment to placebo in the long-term management of Atopic Dermatitis
Interventions
- DRUG placebo
- DRUG Corticosteroid
- DRUG Protopic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-07 |
| Phase | Phase 4 |
What the finished NCT00106496 record still lists
NCT00106496 is an interventional study that assigns participants to a tested intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (21% lower).
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00106496 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00106496 about?
NCT00106496 is a clinical study titled "A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis". The purpose of the study is to determine the impact of topical corticosteroids on the safety and effectiveness of Protopic Ointment in the short-term treatment of moderate to severe Atopic Dermatitis and to compare the safety and effectiveness of Protopic Ointment to placebo in the long-term managem...
What is the current status of trial NCT00106496?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 410 participants. The study started on 2004-10. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00106496?
The interventions under investigation include: placebo (DRUG), Corticosteroid (DRUG), Protopic (DRUG).
Who is sponsoring clinical trial NCT00106496?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00106496's enrollment target sits among peer trials
410 207th of 2000 higher than 1,793 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- NCT05751473 · 410 participants · NA
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia